These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30685416)

  • 1. Epidemiological features and disease-related concerns of a large cohort of Italian patients with active Crohn's disease.
    Armuzzi A; Riegler G; Furfaro F; Baldoni M; Costa F; Fortuna M; Iaquinto G; Paese P; Papi C; Bossa F; Tontini GE; Di Fino S; Gualberti G; Merolla R; Rizzello F
    Dig Liver Dis; 2019 Jun; 51(6):804-811. PubMed ID: 30685416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worries and concerns in a large unselected cohort of patients with Crohn's disease.
    Stjernman H; Tysk C; Almer S; Ström M; Hjortswang H
    Scand J Gastroenterol; 2010 Jun; 45(6):696-706. PubMed ID: 20334474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motivation to pursue anti-TNFα treatment in patients with Crohn's disease - the SPACE motivation study.
    D'Amico F; Peyrin-Biroulet L; Vandromme L; Bouhnik Y; Faure P; Nahon S; Hagege H; Hebuterne X; Benkhalifa S; Nachury M
    Dig Liver Dis; 2020 Sep; 52(9):995-1001. PubMed ID: 32532602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of disease-related concerns and other aspects of health-related quality of life in outpatients with inflammatory bowel disease.
    Mussell M; Böcker U; Nagel N; Singer MV
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1273-80. PubMed ID: 15618832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease.
    Moser G; Tillinger W; Sachs G; Genser D; Maier-Dobersberger T; Spiess K; Wyatt J; Vogelsang H; Lochs H; Gangl A
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):853-8. PubMed ID: 8574717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of health-related quality of life and adherence in Crohn's disease and ulcerative colitis: implications for clinical management.
    Tabibian A; Tabibian JH; Beckman LJ; Raffals LL; Papadakis KA; Kane SV
    Dig Dis Sci; 2015 May; 60(5):1366-74. PubMed ID: 25559754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers.
    Stoppino LP; Della Valle N; Rizzi S; Cleopazzo E; Centola A; Iamele D; Bristogiannis C; Stoppino G; Vinci R; Macarini L
    BMC Med Imaging; 2016 May; 16(1):37. PubMed ID: 27149857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Ostomy on Quality of Life and Functional Status of Crohn's Disease Patients.
    Abdalla MI; Sandler RS; Kappelman MD; Martin CF; Chen W; Anton K; Long MD
    Inflamm Bowel Dis; 2016 Nov; 22(11):2658-2664. PubMed ID: 27661669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients.
    Blondel-Kucharski F; Chircop C; Marquis P; Cortot A; Baron F; Gendre JP; Colombel JF;
    Am J Gastroenterol; 2001 Oct; 96(10):2915-20. PubMed ID: 11693326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trial.
    Louis E; Löfberg R; Reinisch W; Camez A; Yang M; Pollack PF; Chen N; Chao J; Mulani PM
    J Crohns Colitis; 2013 Feb; 7(1):34-43. PubMed ID: 22480772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn's disease.
    Reilly MC; Gerlier L; Brabant Y; Brown M
    Clin Ther; 2008 Feb; 30(2):393-404. PubMed ID: 18343277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple pain measures reveal psycho-social pathology in patients with Crohn's disease.
    Odes S; Friger M; Sergienko R; Schwartz D; Sarid O; Slonim-Nevo V; Singer T; Chernin E; Vardi H; Greenberg D; Israel Ibd Research Nucleus
    World J Gastroenterol; 2017 Feb; 23(6):1076-1089. PubMed ID: 28246482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RELATIONSHIP AMONG PSYCHOLOGICAL WELL-BEING, RESILIENCE AND COPING WITH SOCIAL AND CLINICAL FEATURES IN CROHN'S DISEASE PATIENTS.
    Acciari AS; Leal RF; Coy CSR; Dias CC; Ayrizono MLS
    Arq Gastroenterol; 2019 Aug; 56(2):131-140. PubMed ID: 31460575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience.
    Peyrin-Biroulet L; Salleron J; Filippi J; Reenaers C; Antunes O; Filipe V; Louis E; Hébuterne X; Roblin X
    J Crohns Colitis; 2016 May; 10(5):516-24. PubMed ID: 26802084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor necrosis factor agents reduce corticosteroid use compared with azathioprine in patients with Crohn's disease.
    Kane SV; Jaganathan S; Bedenbaugh AV; Palmer L; Schwartz DA
    Curr Med Res Opin; 2014 Sep; 30(9):1821-6. PubMed ID: 24884302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life and colorectal function in Crohn's disease patients that underwent ileocecal resection during childhood.
    Diederen K; de Ridder L; van Rheenen P; Wolters VM; Mearin ML; de Meij TG; van Wering H; Oomen MW; de Jong JR; Sloots CE; Benninga MA; Kindermann A
    Eur J Pediatr; 2019 Sep; 178(9):1413-1421. PubMed ID: 31327075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PHYSICAL ACTIVITY IN DAILY LIFE, EXERCISE CAPACITY AND QUALITY OF LIFE IN PATIENTS WITH CROHN'S DISEASE ON INFLIXIMAB-INDUCED REMISSION: A PRELIMINARY STUDY.
    Cabalzar AL; Azevedo FM; Lucca FA; Reboredo MM; Malaguti C; Chebli JMF
    Arq Gastroenterol; 2019; 56(4):351-356. PubMed ID: 31618395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TREATMENT OF ANEMIA AND IMPROVEMENT OF QUALITY OF LIFE AMONG PATIENTS WITH CROHN'S DISEASE: experience using ferric carboxymaltose.
    Sobrado CW; Cançado RD; Sobrado LF; Frugis MO; Sobrado MF
    Arq Gastroenterol; 2015 Dec; 52(4):255-9. PubMed ID: 26840464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of surgery on quality of life in Crohn's disease.
    Yazdanpanah Y; Klein O; Gambiez L; Baron P; Desreumaux P; Marquis P; Cortot A; Quandalle P; Colombel JF
    Am J Gastroenterol; 1997 Oct; 92(10):1897-900. PubMed ID: 9382061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.